Gamma-aminobutyric acid, a potential tumor suppressor for small airway-derived lung adenocarcinoma

por Schuller, Hildegard M., Al-Wadei, Hussein A.N., Majidi, Mourad
Publicado 2008

The Tumor Suppressor Gene TUSC2 (FUS1) Sensitizes NSCLC to the AKT Inhibitor MK2206 in LKB1-dependent Manner

por Meng, Jieru, Majidi, Mourad, Fang, Bingliang, Ji, Lin, Bekele, B. Nebiyou, Minna, John D., Roth, Jack A.
Publicado 2013

TUSC2 immunogene enhances efficacy of chemo-immuno combination on KRAS/LKB1 mutant NSCLC in humanized mouse model

por Meraz, Ismail M., Majidi, Mourad, Shao, RuPing, Meng, Feng, Ha, Min Jin, Shpall, Elizabeth, Roth, Jack A.
Publicado 2022

TUSC2(FUS1)-erlotinib Induced Vulnerabilities in Epidermal Growth Factor Receptor(EGFR) Wildtype Non-small Cell Lung Cancer(NSCLC) Targeted by the Repurposed Drug Auranofin

por Xiaobo, Cao, Majidi, Mourad, Feng, Meng, Shao, Ruping, Wang, Jing, Zhao, Yang, Baladandayuthapani, Veerabhadran, Song, Juhee, Fang, Bingliang, Ji, Lin, Mehran, Reza, Roth, Jack A.
Publicado 2016

TUSC2 downregulates PD-L1 expression in non-small cell lung cancer (NSCLC)

por Cao, Xiaobo, Zhao, Yang, Wang, Jing, Dai, Bingbing, Gentile, Emanuela, Lin, Jing, Pu, Xingxiang, Ji, Lin, Wu, Shuhong, Meraz, Ismail, Majidi, Mourad, Roth, Jack A.
Publicado 2017

Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathway...

por Dai, Bingbing, Yan, Shaoyu, Lara-Guerra, Humberto, Kawashima, Hiroyuki, Sakai, Ryo, Jayachandran, Gitanjali, Majidi, Mourad, Mehran, Reza, Wang, Jing, Bekele, B. Nebiyou, Baladandayuthapani, Veerabhadran, Yoo, Suk-Young, Wang, Ying, Ying, Jun, Meng, Feng, Ji, Lin, Roth, Jack A.
Publicado 2015

Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells

por Pataer, Apar, Ozpolat, Bulent, Shao, RuPing, Cashman, Neil R., Plotkin, Steven S., Samuel, Charles E., Lin, Steven H., Kabil, Nashwa N., Wang, Jing, Majidi, Mourad, Fang, Bingliang, Roth, Jack A., Vaporciyan, Ara A., Wistuba, Ignacio I., Hung, Mien-Chie, Swisher, Stephen G.
Publicado 2019

Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells

por Li, Hongyu, Hu, Jing, Wu, Shuhong, Wang, Li, Cao, Xiaobo, Zhang, Xiaoshan, Dai, Bingbing, Cao, Mengru, Shao, Ruping, Zhang, Ran, Majidi, Mourad, Ji, Lin, Heymach, John V., Wang, Michael, Pan, Shiyang, Minna, John, Mehran, Reza J., Swisher, Stephen G., Roth, Jack A., Fang, Bingliang
Publicado 2015

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

por Meraz, Ismail M., Majidi, Mourad, Fang, Bingliang, Meng, Feng, Gao, Lihui, Shao, RuPing, Song, Renduo, Li, Feng, Lissanu, Yonathan, Chen, Huiqin, Ha, Min Jin, Wang, Qi, Wang, Jing, Shpall, Elizabeth, Jung, Sung Yun, Haderk, Franziska, Gui, Philippe, Riess, Jonathan Wesley, Olivas, Victor, Bivona, Trever G., Roth, Jack A.
Publicado 2023

Author Correction: 3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

por Meraz, Ismail M., Majidi, Mourad, Fang, Bingliang, Meng, Feng, Gao, Lihui, Shao, RuPing, Song, Renduo, Li, Feng, Lissanu, Yonathan, Chen, Huiqin, Ha, Min Jin, Wang, Qi, Wang, Jing, Shpall, Elizabeth, Jung, Sung Yun, Haderk, Franziska, Gui, Philippe, Riess, Jonathan Wesley, Olivas, Victor, Bivona, Trever G., Roth, Jack A.
Publicado 2023